Usama Gergis

12PUBLICATIONS
108CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologySocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 28, 2026
Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004.

|Apr 17, 2026
A Phase 2, Open-Label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.

|Jun 30, 2025
Correction: Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation.

Mohamed Amine Bekadja, Dietger Niederwieser, Mohamed A Kharfan-Dabaja

|May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR.

Kitsada Wudhikarn, Megan M Herr, Min Chen

|Mar 02, 2025
Chimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study.

Mohamed A Kharfan-Dabaja, Razan Mohty, Neela Easwar

|Oct 07, 2024
Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation.

Mohamed Amine Bekadja, Dietger Niederwieser, Mohamed A Kharfan-Dabaja

Pageof 2

Frequent Collaborators

5 joint publications

Mohamed A Kharfan-Dabaja

2 joint publications

Alexis Peedin

2 joint publications

Ali Bazarbachi

2 joint publications

Christian Chabanon